Editor: Debomoy K. Lahiri

Advances in Alzheimer Research

Volume 1

eBook: US $29 Special Offer (PDF + Printed Copy): US $133
Printed Copy: US $119
Library License: US $116
ISSN: 2589-2797 (Print)
ISSN: 2214-4358 (Online)
ISBN: 978-1-60805-714-6 (Print)
ISBN: 978-1-60805-495-4 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080549541130101


Alzheimer’s disease (AD) is currently recognized as an untreatable, progressive, degenerative and terminal disease that is globally afflicting an estimated 36 million people and this number is growing in an unabated and frightening manner. Advances in Alzheimer Research, provides researchers with an integrated approach to AD academic literature ranging from basic to advanced clinical research. The series highlights the latest information in order to unravel the origin, pathogenesis and prevention of AD. The purpose of this book series is, therefore, to capture and discuss both, improvements towards the diagnosis and potential treatment of AD by established and novel strategies.

This first volume of the series provides an important mechanism to bring individuals having a variety of scientific interests and expertise under one roof to specifically focus on AD and related dementias. This volume presents articles on beta amyloid protein targets as well as research on secretase enzyme systems among other topics that deal with AD therapy.


- Pp. i-vi (6)
Debomoy K. Lahiri
Download Free

List of Contributors

- Pp. vii-xi (5)
Debomoy K. Lahiri
Download Free

How and When Environmental Agents and Dietary Factors Affect the Course of Alzheimer’s Disease: The “LEARn” Model (Latent Early-Life Associated Regulation) May Explain the Triggering of AD

- Pp. 3-27 (25)
Debomoy K. Lahiri, Bryan Maloney, Md Riyaz Basha, Yuan Wen Ge, Nasser H. Zawia
View Abstract

Therapeutics Targeting Intracellular Amyloid β-Protein in Alzheimer’s Disease: A Novel Effect of Apomorphine

- Pp. 28-46 (19)
Yasumasa Ohyagi
View Abstract

Protection Mechanisms Against Aβ42 Aggregation

- Pp. 47-64 (18)
Yilin Yan, Christopher Connors, Chunyu Wang
View Abstract

An Increase in Aβ42 in the Prefrontal Cortex is Associated with a Reversal Learning Impairment in Alzheimer’s Disease Model Tg2576 APPsw Mice

- Pp. 65-80 (16)
Jia-Min Zhuo, Annamalai Prakasam, Melissa E. Murray, Hai-Yan Zhang, Mark G. Baxter, Kumar Sambamurti, Michelle M. Nicolle
View Abstract

The Regulation of &#946;APP and PrP<sup>c</sup> Processing by &#945;-Secretase

- Pp. 81-104 (24)
Bruno Vincent, Moustapha Cissé, Claire Sunyach, Marie-Victoire Guillot-Sestier, Frédéric Checler
View Abstract

Regulation and Activation of Metalloproteinase-Mediated APP &#945;-Secretase Cleavage

- Pp. 105-127 (23)
Rolf Postina
View Abstract

Taking Down the Unindicted Co-Conspirators of Amyloid &#946;-Peptide-Mediated Neuronal Death: Shared Gene Regulation of BACE1 and APP Genes Interacting with CREB, Fe65 and YY1 Transcription Factors

- Pp. 128-146 (19)
Debomoy K. Lahiri, Yuan-Wen Ge, Jack T. Rogers, Kumar Sambamurti, Nigel H. Greig, Bryan Maloney
View Abstract

The What, Where, and How of &#947;-Secretase Complex Assembly

- Pp. 147-186 (40)
Daniel R. Dries, Gang Yu
View Abstract

Pro-Inflammatory Cytokines and Anti-Inflammatory Drugs Modulate Glial Expression of Apolipoprotein E Protein

- Pp. 187-204 (18)
Judes Poirier, Rosanne Aleong, Dorothée Domenger
View Abstract

Lipoprotein Receptors in Alzheimer´s Disease: Beyond Lipoprotein Transport

- Pp. 205-233 (29)
Wladislaw Maier, Sebastian Jaeger, Claus U. Pietrzik
View Abstract

Tau-Induced Neurodegeneration in Alzheimer Disease and Related Tauopathies

- Pp. 234-259 (26)
Alejandra del C. Alonso, Bin Li, Inge Grundke-Iqbal, Khalid Iqbal
View Abstract

Prevalence of Neuropsychiatric Symptoms in Alzheimer’s Disease and Vascular Dementia

- Pp. 260-280 (21)
Manuel Fernández-Martínez, Jassica Castro, Ana Molano, Juan J. Zarranz, Rosa M. Rodrigo, Rafael Ortega
View Abstract

Fatty Aspirin: A New Perspective in the Prevention of Dementia of Alzheimer’s Type?

- Pp. 281-318 (38)
Massimo F.L. Pomponi, Massimiliano Pomponi, Giovanni Gambassi
View Abstract


- Pp. 319-329 (11)
Debomoy K. Lahiri
Download Free


.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.